Red Tree Venture — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Goldilocks TherapeuticsDec 2019SEC filingmedium confidence
BiotechBedford, US
Arthur Klausner(Executive Officer, Director)
BoardScott Minick(Director)
Board seatKrishna Polu· per SEC Form D · $1.2M raise · filed Apr 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.